Literature DB >> 11160469

Detection of subarachnoid haemorrhage with magnetic resonance imaging.

P Mitchell1, I D Wilkinson, N Hoggard, M N Paley, D A Jellinek, T Powell, C Romanowski, T Hodgson, P D Griffiths.   

Abstract

OBJECTIVES: To measure the sensitivity and specificity of five MRI sequences to subarachnoid haemorrhage.
METHODS: Forty one patients presenting with histories suspicious of subarachnoid haemorrhage (SAH) were investigated with MRI using T1 weighted, T2 weighted, single shot fast spin echo (express), fluid attenuation inversion recovery (FLAIR), and gradient echo T2* sequences, and also by CT. Lumbar puncture was performed in cases where CT was negative for SAH. Cases were divided into acute (scanned within 4 days of the haemorrhage) and subacute (scanned after 4 days) groups.
RESULTS: The gradient echo T2* was the most sensitive sequence, with sensitivities of 94% in the acute phase and 100% in the subacute phase. Next most sensitive was FLAIR with values of 81% and 87% for the acute and subacute phases respectively. Other sequences were considerably less sensitive.
CONCLUSIONS: MRI can be used to detect subacute and acute subarachnoid haemorrhage and has significant advantages over CT in the detection of subacute subarachnoid haemorrhage. The most sensitive sequence was the gradient echo T2*.

Entities:  

Mesh:

Year:  2001        PMID: 11160469      PMCID: PMC1737199          DOI: 10.1136/jnnp.70.2.205

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  15 in total

1.  Acute subarachnoid haemorrhage: detection with magnetic resonance imaging.

Authors:  H Chrysikopoulos; N Papanikolaou; J Pappas; A Papandreou; A Roussakis; J Vassilouthis; J Andreou
Journal:  Br J Radiol       Date:  1996-07       Impact factor: 3.039

Review 2.  The diagnosis of subarachnoid haemorrhage.

Authors:  M Vermeulen; J van Gijn
Journal:  J Neurol Neurosurg Psychiatry       Date:  1990-05       Impact factor: 10.154

Review 3.  Fluid-attenuated inversion recovery (FLAIR): clinical prospectus of current and future applications.

Authors:  R Kates; D Atkinson; M Brant-Zawadzki
Journal:  Top Magn Reson Imaging       Date:  1996-12

4.  MR diagnosis of subacute and chronic subarachnoid hemorrhage: comparison with CT.

Authors:  T Ogawa; A Inugami; H Fujita; J Hatazawa; E Shimosegawa; K Noguchi; T Okudera; I Kanno; K Uemura; A Suzuki
Journal:  AJR Am J Roentgenol       Date:  1995-11       Impact factor: 3.959

5.  MR of acute subarachnoid hemorrhage: a preliminary report of fluid-attenuated inversion-recovery pulse sequences.

Authors:  K Noguchi; T Ogawa; A Inugami; H Toyoshima; T Okudera; K Uemura
Journal:  AJNR Am J Neuroradiol       Date:  1994-11       Impact factor: 3.825

6.  Acute subarachnoid hemorrhage: MR imaging with fluid-attenuated inversion recovery pulse sequences.

Authors:  K Noguchi; T Ogawa; A Inugami; H Toyoshima; S Sugawara; J Hatazawa; H Fujita; E Shimosegawa; I Kanno; T Okudera
Journal:  Radiology       Date:  1995-09       Impact factor: 11.105

7.  Computed tomography in the diagnosis of subarachnoid haemorrhage and ruptured aneurysm.

Authors:  J van Gijn; K J van Dongen
Journal:  Clin Neurol Neurosurg       Date:  1980       Impact factor: 1.876

8.  The time course of aneurysmal haemorrhage on computed tomograms.

Authors:  J van Gijn; K J van Dongen
Journal:  Neuroradiology       Date:  1982       Impact factor: 2.804

9.  Subarachnoid space disease: diagnosis with fluid-attenuated inversion-recovery MR imaging and comparison with gadolinium-enhanced spin-echo MR imaging--blinded reader study.

Authors:  M B Singer; S W Atlas; B P Drayer
Journal:  Radiology       Date:  1998-08       Impact factor: 11.105

10.  Xanthochromia after subarachnoid haemorrhage needs no revisitation.

Authors:  M Vermeulen; D Hasan; B G Blijenberg; A Hijdra; J van Gijn
Journal:  J Neurol Neurosurg Psychiatry       Date:  1989-07       Impact factor: 10.154

View more
  37 in total

Review 1.  Diagnosis of subarachnoid hemorrhage.

Authors:  Jonathan A Edlow
Journal:  Neurocrit Care       Date:  2005       Impact factor: 3.210

Review 2.  Spectrophotometry for cerebrospinal fluid pigment analysis.

Authors:  Axel Petzold; Lindsay T Sharpe; Geoffrey Keir
Journal:  Neurocrit Care       Date:  2006       Impact factor: 3.210

Review 3.  Imaging Evaluation of Acute Traumatic Brain Injury.

Authors:  Christopher A Mutch; Jason F Talbott; Alisa Gean
Journal:  Neurosurg Clin N Am       Date:  2016-08-10       Impact factor: 2.509

Review 4.  Neuroimaging in Secondary Headache Disorders.

Authors:  Priyanka Chaudhry; Deborah I Friedman
Journal:  Curr Pain Headache Rep       Date:  2015-07

5.  Susceptibility-weighted imaging: a new tool for detection of intratumoral bleeding and subarachnoid hemorrhage--report of two cases.

Authors:  S S Baldawa; K Bele; G Menon; C V George; M Abraham; S Nair
Journal:  Clin Neuroradiol       Date:  2011-09-09       Impact factor: 3.649

6.  Neuroradiologic Diagnosis of Minor Leak prior to Major SAH: Diagnosis by T1-FLAIR Mismatch.

Authors:  S Oda; M Shimoda; A Hirayama; M Imai; F Komatsu; H Shigematsu; J Nishiyama; M Matsumae
Journal:  AJNR Am J Neuroradiol       Date:  2015-05-14       Impact factor: 3.825

Review 7.  Intracranial hemorrhage.

Authors:  J Alfredo Caceres; Joshua N Goldstein
Journal:  Emerg Med Clin North Am       Date:  2012-08       Impact factor: 2.264

Review 8.  Aneurysmal subarachnoid haemorrhage: guidance in making the correct diagnosis.

Authors:  W A Liebenberg; R Worth; G B Firth; J Olney; J S Norris
Journal:  Postgrad Med J       Date:  2005-07       Impact factor: 2.401

9.  MRI in acute subarachnoid haemorrhage; findings with a standardised stroke protocol.

Authors:  J B Fiebach; P D Schellinger; K Geletneky; P Wilde; M Meyer; W Hacke; K Sartor
Journal:  Neuroradiology       Date:  2003-12-04       Impact factor: 2.804

Review 10.  Update on subarachnoid haemorrhage.

Authors:  José M Ferro; P Canhão; R Peralta
Journal:  J Neurol       Date:  2008-03-25       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.